Concepedia

Erika Sutanto‐Ward

ES

Statistics

Publications

15

Citations

2K

H-Index

14

Active since

1992

Affiliations

Lankenau Institute for Medical Research(Current)

Thomas Jefferson University

Sidney Kimmel Cancer Center

Drexel University

Fox Chase Cancer Center

Erika Sutanto‐Ward is an author at Lankenau Institute for Medical Research specializing in medicine, oncology, and molecular oncology.

Publications per year

1992–2021

15

Publications

15

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Alexander J. Muller, James B. DuHadaway, Preston S. Donover et al. · Nature Medicine · 2005 · 1.1K citations

, , +16

IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

Courtney Smith, Mee Young Chang, Katherine H. Parker et al. · Cancer Discovery · 2012 · 324 citations · Full text

, , +16

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

Tinku Banerjee, James B. DuHadaway, Paul Gaspari et al. · Oncogene · 2007 · 172 citations

, , +5

IDO1 is an Integral Mediator of Inflammatory Neovascularization

Arpita Mondal, Courtney Smith, James B. DuHadaway et al. · EBioMedicine · 2016 · 90 citations · Full text

, , +15

Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion

Alexander J. Muller, James B. DuHadaway, Mee Young Chang et al. · Cancer Immunology Immunotherapy · 2010 · 53 citations · Full text

, , +14

1–5 of 15